An extended substrate spectrum of the proton organic cation antiporter and relation to other cation transporters
Basic & Clinical Pharmacology & Toxicology · 2024
DOI: 10.1111/bcpt.14090 ↗Kurz gefasst
Fachartikel in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, 2024. Verfasst von Cauzar Ali Khan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Pharmacology, University Medical Center Göttingen, Georg-August-University Göttingen, Germany. Hauptthemen laut MEDLINE: Organic Cation Transport Proteins, Blood-Brain Barrier. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, University Medical Center, University of Göttingen.
Abstract (Originalsprache)
Most central nervous system (CNS) active drugs are organic cations, which need carrier proteins for efficient transfer through the blood–brain barrier (BBB). A genetically still unidentified proton organic cation (H + /OC) antiporter is found in several tissues, including endothelial cells of the BBB. We characterized the substrate spectrum of the H + /OC antiporter and the overlap in substrate spectrum with OCTN1, OCTN2 or OCT3 by screening 87 potential substrates for transport activity. Based on high antiport rates, 45 of the tested substances were substrates of the H + /OC antiporter. They included antidepressants (like tranylcypromine or nortriptyline), antipsychotics (like levomepromazine) and local anaesthetics. Concentration‐dependent transport was confirmed for 38 of the substrates. Transport uptake depending on a pH gradient across the cell membrane confirmed that 43 drugs were indeed substrates of the H + /OC antiporter. However, the patterns of pH dependence differed between the substrates, possibly indicating different modes of transport or the existence of multiple antiporter proteins. The substrate overlap between the H + /OC antiporter and OCTN1, OCTN2 or OCT3 was minimal, indicating that the latter three are not the proteins underlying the H + /OC antiporter activity. Overall, about 50% of positively charged drugs may be substrates of the antiporter, which may be the most important membrane transport protein for many drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Clinical Pharmacology, University Medical Center Göttingen, Georg-August-University Göttingen, Germany.
ORCID-Profile: Kyra-Elisa Maria Redeker
Förderung
- Deutsche Forschungsgemeinschaft
- University Medical Center, University of Göttingen
Zitieren
APA
Ali Khan, C., Kirsch, N., Brockmöller, J., & Redeker, K. M. (2024). An extended substrate spectrum of the proton organic cation antiporter and relation to other cation transporters. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.14090
Vancouver
Ali Khan C, Kirsch N, Brockmöller J, Redeker KM. An extended substrate spectrum of the proton organic cation antiporter and relation to other cation transporters. Basic & Clinical Pharmacology & Toxicology. 2024. doi:10.1111/bcpt.14090
BibTeX
@article{AliKhan2024,
author = {Ali Khan, Cauzar and Kirsch, Nicolai and Brockmöller, Jürgen and Redeker, Kyra-Elisa Maria},
title = {An extended substrate spectrum of the proton organic cation antiporter and relation to other cation transporters},
journal = {Basic & Clinical Pharmacology & Toxicology},
year = {2024},
doi = {10.1111/bcpt.14090}
}
EUVIMED